Injectable semaglutide may be safer than the oral form, based on current research
Effectiveness of intermittent fasting for weight loss: Its not just when you eat, but what you eat, too
Do I have other obesity-related health conditions that this treatment might help
The objective of the STEP 1 study was to compare the effect of a semaglutide SC 2.4 mg injection once weekly versus placebo as an adjunct to a reduced-calorie diet and increased physical activity in patients with overweight or obesity on body weight (primary objective), and cardiovascular risk factors, clinical outcome assessment, glucose metabolism, and other factors related to body weight (secondary objectives)
For anyone unfamiliar with the injection process, the complete peptide injection guide walks through technique step by step
Long F, Challa TD, Ding L, et al